
numares HEALTH provides software-based diagnostic tests that analyze metabolic and biomarker patterns to support clinical decision-making. The company combines high-throughput nuclear magnetic resonance (NMR) spectroscopy (the FDA-cleared AXINON® System) with its Magnetic Group Signaling® (MGS®) technology and machine learning applied to metabolomics data to generate standardized test results. numares offers these capabilities as clinical diagnostic test systems and services for use in cardiovascular, kidney, liver and neurological disease assessment. The company operates as a diagnostics and clinical analytics provider focused on commercial NMR analytics in Europe and global regulatory-cleared solutions.

numares HEALTH provides software-based diagnostic tests that analyze metabolic and biomarker patterns to support clinical decision-making. The company combines high-throughput nuclear magnetic resonance (NMR) spectroscopy (the FDA-cleared AXINON® System) with its Magnetic Group Signaling® (MGS®) technology and machine learning applied to metabolomics data to generate standardized test results. numares offers these capabilities as clinical diagnostic test systems and services for use in cardiovascular, kidney, liver and neurological disease assessment. The company operates as a diagnostics and clinical analytics provider focused on commercial NMR analytics in Europe and global regulatory-cleared solutions.